What EU Expansion Means for the Pharma Industry
Executive Summary
The impact on the pharmaceutical industry of EU expansion in 2004 remains unclear. It may be an opportunity to drive growth in Europe to levels that could potentially rival the US, or it could result in increases to parallel trade, further lowering competitiveness and drug prices in Europe. IMS consultant Janice Haigh assesses the likelihood of both potential outcomes.